In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

Biography

Bengt R. Danielsson, MD, PhD

Vice President, PharmaNet Consulting
504 Carnegie Center
Princeton, NJ 08540
USA

Tel: 202 835 1352
Fax: 609 720 7900

E-mail: bdanielsson@pharmanet.com

Expertise: Toxicology, pharmacology, pain control, reproductive health, autoradiography

 

Dr. Danielsson has worked in the pharmaceutical industry for nearly 30 years. Before coming to PharmaNet, Dr. Danielsson served as Scientific Director/Professor in Pharmacology and Toxicology for the Swedish Medical Product Agency. While there, he also served as a member of the EMEA/CHMP Innovative Medicine Task Force, representing the EU Pharmacology & Toxicology group and was the Swedish representative on the CHMP/EU Safety and CHMP/EU Cell-based Products working parties.

 

Before that, Dr. Danielsson worked for Astra AB and AstraZeneca where he held progressive positions of responsibility, most recently as Global Director, Clinical Interface Support and Global Science Leader, Reproductive Toxicology. He is also an Adjunct Professor in Pharmaceutical Toxicology at Uppsala University. Dr. Danielsson has published extensively, with more than 90 published articles and reviews, mainly on reproductive toxicology and drug safety evaluation.

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390